The Immunology (IM) program is devoted to enhancing our understanding of the function of the innate and adaptive immune system in the pathogenesis of malignant disease. There are three broad themes in the program?(1) innate immunity and the role of checkpoint innate sensors in the initiation of malignant disease; (2) adaptive immunity and the role of effector and regulatory T cells and B cells in the biology of malignant disease and graft-versus-host disease (GVHD); and (3) tumor vaccines and translational immunotherapy. The last theme focuses on nanoparticle delivery and vaccine development and a new area using modified T cells for adoptive cellular therapy. Significant highlights of the program have been seminal discoveries regarding the negative immunoregulatory role of innate sensing proteins and their role in cancer development, the generation of a novel mouse model to investigate viral induced carcinogenesis in the liver, completion of the largest clinical trial combining an antibody and tumor vaccine approach given with chemotherapy for the treatment of women with metastatic breast cancer and novel findings regarding the function of immunosuppressive pathways and immune cells in the growth of solid tumors. The third programmatic area, translational immunotherapy, is greatly enhanced by the building in 2015 of the sole cellular expansion GMP facility in the state of North Carolina and plans for genetically modified autologous T cell infusions for the treatment of patients with acute lymphoblastic leukemia, multiple myeloma and Hodgkin lymphoma in 2016. Five high profile recruits, including three junior faculty members, Edward Miao PhD, Maureen Su MD PhD, and Yuliya Pylayeva-Gupta PhD, and two senior recruits from the Cell and Gene Therapy Program at Baylor University of Medicine, Gianpietro Dotti MD and Barbara Savoldo MD PhD have joined the program since the last submission. The program is led by Jenny Ting PhD Kenan Professor of Genetics and the leader of the Translational Immunology Center at the University of North Carolina who is a world's expert on the function of proteins that mediate innate immune responses, and Jonathan Serody MD Thomas Professor of Medicine, Microbiology and Immunology and the Associate Director for Translational Sciences in the Cancer Center who is an expert on the biology of GVHD and tumor vaccines and the tumor microenvironment. There are 19 program members from five different departments in the Medical School. During the last funding period, program members have published 406 cancer-related articles (28% collaborative). In 2014, our program members held 58 grants and $17.7M (total cost) in annual extramural funding, including 6 grants and $1.7M (total costs) from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834871
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Townsley, Loni; Yannarell, Sarah M; Huynh, Tuanh Ngoc et al. (2018) Cyclic di-AMP Acts as an Extracellular Signal That Impacts Bacillus subtilis Biofilm Formation and Plant Attachment. MBio 9:
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Hall, Marissa G; Mendel, Jennifer R; Noar, Seth M et al. (2018) Why smokers avoid cigarette pack risk messages: Two randomized clinical trials in the United States. Soc Sci Med 213:165-172
Cholon, Deborah M; Gentzsch, Martina (2018) Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 17:S52-S60
Tappata, Manaswita; Eluri, Swathi; Perjar, Irina et al. (2018) Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy 73:2088-2092
Che, Tao; Majumdar, Susruta; Zaidi, Saheem A et al. (2018) Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell 172:55-67.e15
Hu, Peirong; Bi, Yanmin; Ma, Hong et al. (2018) Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Ther 25:454-472
Cranston, Ross D; Cespedes, Michelle S; Paczuski, Pawel et al. (2018) High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298. Sex Transm Dis 45:266-271
DeBono, Nathan L; Robinson, Whitney R; Lund, Jennifer L et al. (2018) Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. J Womens Health (Larchmt) 27:377-386
Okolie, Onyinyechukwu; Irvin, David M; Bago, Juli R et al. (2018) Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection. PLoS One 13:e0198596

Showing the most recent 10 out of 1525 publications